Thu.Oct 26, 2023

article thumbnail

From NASH to MASH: New Terms for Liver Diseases Unveiled at the 2023 Cardiometabolic Health Congress

Cardiometabolic Health Congress

A session at the 18 th Annual Cardiometabolic Health Congress (CMHC), explored the intersection of cardiometabolic conditions such as obesity and insulin resistance with liver disease, beginning with some important new updates on the preferred terms for these diseases. Robert H. Eckel, MD On Thursday, Oct. 19, 2023, attendees of the 18 th Annual CMHC in Boston heard from experts in hepatology and endocrinology in a session titled The Intersection of MASH and Cardiometabolic Risk: Applying Advanc

article thumbnail

The Next Paradigm: Advancing Medical Education in Colon & Rectum Surgery

ADN Center of Excellence

Dear doctors, welcome to a new chapter in our medical training journey! As a company that has long been recognized for its commitment to providing top-notch education in interventional cardiology, we're excited to announce our foray into the field of Colon and Rectum Surgery. Our dedication to excellence and continuous learning remains unwavering, and we are eager to extend our expertise to this vital area of medicine.

article thumbnail

Brugada Syndrome: Diagnosis and Risk Stratification

All About Cardiovascular System and Disorders

Brugada Syndrome: Diagnosis and Risk Stratification Hello friends, this is the modified version of my talk at Indian Heart Rhythm Society Conference, New Delhi, 2023, on Brugada Syndrome. Hope you will enjoy this session. Initial description of Brugada syndrome in 1992 was that of syncopal episodes and/or sudden death in persons with structurally normal heart and a characteristic ECG pattern of right bundle branch block with ST segment elevation in leads V1 to V3.

article thumbnail

Making Waves from Mayo clinic: Artificial Intelligence-Augmented ECG Interpretation Using Smartphone Technology with Anthony Kashou and Robert Herman

Dr. Smith's ECG Blog

@RobertHermanMD on Making Waves from Mayo clinic. Artificial Intelligence-Augmented ECG Interpretation Using Smartphone Technology @TheEKGGuy [link] == MY Comment , by K EN G RAUER, MD ( 10/26 /2023 ): == Our THANKS to Drs. Anthony Kashou & Robert Herman for their wonderful ongoing work toward continued evolution and improvement of clinical ECG utilization.

article thumbnail

The Next Paradigm: Advancing Medical Education in Colon & Rectum Surgery

ADN Center of Excellence

Dear doctors, welcome to a new chapter in our medical training journey! As a company that has long been recognized for its commitment to providing top-notch education in interventional cardiology, we're excited to announce our foray into the field of Colon and Rectum Surgery. Our dedication to excellence and continuous learning remains unwavering, and we are eager to extend our expertise to this vital area of medicine.

article thumbnail

An Update on Betrixaban, The Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis

Journal of Cardiovascular Pharmacology

Abstract: Venous thromboembolism (VTE), comprising deep-vein thrombosis (DVT) and pulmonary embolism (PE), stands as the third leading cause of vascular-related mortality on a global scale. Anticoagulation prophylaxis undeniably ensures a significant reduction in the risk of DVT, while simultaneously exposing individuals to an elevated likelihood of experiencing both major and minor bleeding events.

article thumbnail

Mobile stroke units increase odds of averting stroke

Science Daily - Stroke

Receiving a clot-busting drug in an ambulance-based mobile stroke unit (MSU) increases the likelihood of averting strokes and complete recovery compared with standard hospital emergency care, according to researchers.

Stroke 40

More Trending

article thumbnail

Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months Following Medication Escalation: The RADIANCE Clinical Trial Program

Circulation

Circulation, Ahead of Print. Background:The RADIANCE-HTN SOLO, RADIANCE-HTN TRIO, and RADIANCE II randomized, sham-controlled trials independently met their primary endpoint of a greater reduction in daytime ambulatory systolic blood pressure (SBP) at 2 months after ultrasound renal denervation (uRDN) in patients with hypertension. To characterize the longer-term effectiveness and safety of uRDN vs. sham at 6 months, following the blinded addition of antihypertensive treatments (AHT), we pooled

article thumbnail

Response by Pua et al to Letter Regarding Article, “Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study”

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Volume 16, Issue 11 , Page e016087, November 1, 2023.

Article 40
article thumbnail

Proteinopathy: Shared Feature between the Heart and Brain in Alzheimer’s Disease

Journal of Cardiovascular Pharmacology

No abstract available

40
article thumbnail

Letter by Chen and Liang Regarding Article, “Impact of Diabetes on Myocardial Fibrosis in Patients With Hypertension: The REMODEL Study”

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Volume 16, Issue 11 , Page e016023, November 1, 2023.

Article 40